Skip to content

Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.

Powered by THEMA

Current Report · Items 2.02, 9.01 · 8-K

Eli Lilly & Co.

LLYNYSEEQUITYCurrent

Results of Operations and Financial Condition

Item 2.02. Results of Operations and Financial Condition. The information in this Item 2.02, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to the liabilities of that Section and shall not be incorporated by reference into any registration sta…

Filed Oct 29, 2026Accepted Oct 29, 2026, 7:03 AM EDTCIK 59478Accession 0000059478-26-000104

View company →Permanent SEC source ↗

Press release in this filing

Lilly reports third-quarter 2026 financial results, raises full-year guidance and highlights regulatory progress across the portfolio →

Company context

Current securities

LLYNYSE · EQUITY · Current

Recent company filings

Registered securities in this filing

ELI LILLY AND COMPANY · 8-K · Filed 2026-10-29

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Common Stock (no par value)

Symbol: LLY
Exchange: NYSE
Classification: COMMON
Status: Current

Filing context

Context: c-2

Dimensions: us-gaap:StatementClassOfStockAxis

2.125% Notes due 2030

Symbol: LLY30
Exchange: NYSE
Classification: DEBT

Filing context

Context: c-3

Dimensions: us-gaap:StatementClassOfStockAxis

0.625% Notes due 2031

Symbol: LLY31
Exchange: NYSE
Classification: DEBT

Filing context

Context: c-4

Dimensions: us-gaap:StatementClassOfStockAxis

0.500% Notes due 2033

Symbol: LLY33
Exchange: NYSE
Classification: DEBT

Filing context

Context: c-5

Dimensions: us-gaap:StatementClassOfStockAxis

6.77% Notes due 2036

Symbol: LLY36
Exchange: NYSE
Classification: DEBT

Filing context

Context: c-6

Dimensions: us-gaap:StatementClassOfStockAxis

1.625% Notes due 2043

Symbol: LLY43
Exchange: NYSE
Classification: DEBT

Filing context

Context: c-7

Dimensions: us-gaap:StatementClassOfStockAxis

1.700% Notes due 2049

Symbol: LLY49A
Exchange: NYSE
Classification: DEBT

Filing context

Context: c-8

Dimensions: us-gaap:StatementClassOfStockAxis

1.125% Notes due 2051

Symbol: LLY51
Exchange: NYSE
Classification: DEBT

Filing context

Context: c-9

Dimensions: us-gaap:StatementClassOfStockAxis

1.375% Notes due 2061

Symbol: LLY61
Exchange: NYSE
Classification: DEBT

Filing context

Context: c-10

Dimensions: us-gaap:StatementClassOfStockAxis

Accession 000005947826000104 · 9 registered-security cover members

Read the exact SEC filing ↗

Disclosure sections

Items 2.02, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 2.02Item 2.02 - Results of Operations

Item 2.02. Results of Operations and Financial Condition. The information in this Item 2.02, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to the liabilities of that Section and shall not be incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933 or the Exchange Act, except as otherwise expressly stated in such filing. Attached hereto as Exhibit 99.1 and incorporated by reference into this Item 2.02 is a copy of the press release, dated October 29, 2026, announcing the financial results of Eli Lilly and Company for the quarter ended September 30, 2026.